KYBELLA® (deoxycholic acid) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults.
The safe and effective use of KYBELLA® for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended.
2 vials minimum
Kybella Injections Before & After
What are the benefits of Kybella?
Kybella is the only injectable treatment of its kind. According to studies and clinical use, this FDA-approved drug is an excellent alternative to liposuction. It offers a non-surgical, no downtime approach to stubborn double-chin fat called submental fullness. Some of the benefits of Kybella include proven safety and efficiency, minimal downtime, if any, and consistent results.
Although Kybella works differently than surgical liposuction, it can achieve results that last indefinitely. Fat cells are destroyed and do not grow back. However, it is necessary to avoid significant weight gain to prevent fat cells under the chin from expanding.
The biggest advantage of Kybella is that it works. Patients who undergo treatment feel better about their appearance due to the elimination of a double-chin. Without excess fat, the face looks thinner and may even look younger. The combination of improvements makes most patients feel better about their appearance.
Who are the ideal candidates for Kybella?
Most adults who are interested in eliminating double-chin are good candidates for Kybella. We conduct a thorough consultation so that we can understand each patient’s concerns and desired outcome. This consultation also allows us to discuss how Kybella works and what patients can expect. Given all the necessary information, patients can make a confident decision about whether or not Kybella is their ideal treatment for their double-chin.
How is Kybella Performed?
Kybella injections may be administered right after our consultation. It may be necessary to schedule multiple sessions of injections to achieve the desired outcome. While some patients may see acceptable improvement after just one round of injections, most need 3 to 4 sessions to fully eradicate excess fat cells from under the chin.
Each treatment session involves cleansing the skin under the chin and on the upper neck. A template is then used to create an injection map. The skin is marked with a special pen to identify where each injection should be given. A local anesthetic cream may be applied at this time to allow sufficient absorption for optimal comfort. Injections are administered once the cream is removed. Though multiple injections are made, this part of the appointment typically takes only a few minutes.
What is the recovery from Kybella?
Kybella is a liquid that is inserted into the subcutaneous layer of fat. It does not immediately get absorbed by fat cells. Instead, the deoxycholic acid in Kybella breaks down the walls of fat cells to destroy them. Because the fluid is under the skin for a few days, patients can expect noticeable swelling. This may feel slightly odd but does not hurt. Swelling subsides as the deoxycholic acid is absorbed by the cells.
Patients need not follow any special instructions after their treatment. Depending on social engagements or work, some people wear a high-neck collar or scarf to disguise the swelling of the upper neck.
How much does Kybella cost?
The cost of Kybella can vary from one person to another based on the number of injections and treatment sessions that are needed. The number of injections and treatments determines how many vials of the product we will need to use. Our consultation and assessment of submental fullness guide us in treatment planning. After our discussion with you, we will have an accurate price quote to provide.
Important Safety Information
KYBELLA® is contraindicated in the presence of infection at the injection sites.
Warnings and Precautions
Marginal Mandibular Nerve Injury
Cases of marginal mandibular nerve injury, manifested as an asymmetric smile or facial muscle weakness, were reported in 4% of subjects in the clinical trials; all cases resolved spontaneously (range 1-298 days, median 44 days). KYBELLA® should not be injected into or in close proximity to the marginal mandibular branch of the facial nerve.
Dysphagia occurred in 2% of subjects in the clinical trials in the setting of administration-site reactions, eg, pain, swelling, and induration of the submental area; all cases of dysphagia resolved spontaneously (range 1-81 days, median 3 days). Avoid use of KYBELLA® in patients with current or prior history of dysphagia as treatment may exacerbate the condition.
In clinical trials, 72% of subjects treated with KYBELLA® experienced hematoma/bruising. KYBELLA® should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet or anticoagulant therapy as excessive bleeding or bruising in the treatment area may occur.
Risk of Injecting Into or in Proximity to Vulnerable Anatomic Structures
To avoid the potential of tissue damage, KYBELLA® should not be injected into or in close proximity (1 cm-1.5 cm) to salivary glands, lymph nodes, and muscles.
The most commonly reported adverse reactions in the pivotal clinical trials were: injection site edema/swelling, hematoma/bruising, pain, numbness, erythema, and induration.
Schedule Your Consultation Today
If you're interested in learning more about kybella injections please contact us for a consultation at (818) 662-5005 or fill out our contact us form below. We will discuss your needs and concerns, and determine your best course of action.